Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106428826 | 10642882 | 6 | F | 201309 | 20160705 | 20141210 | 20160711 | PER | US-PFIZER INC-2014338190 | PFIZER | 59.00 | YR | F | Y | 94.33000 | KG | 20160711 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106428826 | 10642882 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 2X/DAY | U | 1472858 | 21446 | 150 | MG | CAPSULE, HARD | BID | ||||
| 106428826 | 10642882 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 2X/DAY | U | L05303 | 21446 | 150 | MG | CAPSULE, HARD | BID | ||||
| 106428826 | 10642882 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 2X/DAY | U | 21446 | 150 | MG | CAPSULE, HARD | BID | |||||
| 106428826 | 10642882 | 4 | SS | LYRICA | PREGABALIN | 1 | U | 21446 | CAPSULE, HARD | ||||||||||
| 106428826 | 10642882 | 5 | SS | LYRICA | PREGABALIN | 1 | U | 21446 | CAPSULE, HARD | ||||||||||
| 106428826 | 10642882 | 6 | SS | LYRICA | PREGABALIN | 1 | U | 21446 | CAPSULE, HARD | ||||||||||
| 106428826 | 10642882 | 7 | SS | LYRICA | PREGABALIN | 1 | U | 21446 | CAPSULE, HARD | ||||||||||
| 106428826 | 10642882 | 8 | SS | LYRICA | PREGABALIN | 1 | U | 21446 | CAPSULE, HARD | ||||||||||
| 106428826 | 10642882 | 9 | SS | LYRICA | PREGABALIN | 1 | U | 21446 | CAPSULE, HARD | ||||||||||
| 106428826 | 10642882 | 10 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 106428826 | 10642882 | 11 | C | GLYBURIDE. | GLYBURIDE | 1 | UNK | 0 | |||||||||||
| 106428826 | 10642882 | 12 | C | LOVAZA | OMEGA-3-ACID ETHYL ESTERS | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106428826 | 10642882 | 1 | Diabetic foot |
| 106428826 | 10642882 | 2 | Neuralgia |
| 106428826 | 10642882 | 3 | Neuropathy peripheral |
| 106428826 | 10642882 | 4 | Hypoaesthesia |
| 106428826 | 10642882 | 5 | Paraesthesia |
| 106428826 | 10642882 | 6 | Pain in extremity |
| 106428826 | 10642882 | 7 | Burning sensation |
| 106428826 | 10642882 | 8 | Type 2 diabetes mellitus |
| 106428826 | 10642882 | 9 | Hyperglycaemia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106428826 | 10642882 | Burning sensation | |
| 106428826 | 10642882 | Insomnia | |
| 106428826 | 10642882 | Pain in extremity | |
| 106428826 | 10642882 | Peripheral coldness | |
| 106428826 | 10642882 | Sleep disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 106428826 | 10642882 | 1 | 201304 | 0 | ||
| 106428826 | 10642882 | 2 | 201307 | 20141207 | 0 | |
| 106428826 | 10642882 | 3 | 201412 | 0 | ||
| 106428826 | 10642882 | 10 | 2010 | 0 | ||
| 106428826 | 10642882 | 11 | 2010 | 0 | ||
| 106428826 | 10642882 | 12 | 2014 | 0 |